Browse > Article
http://dx.doi.org/10.13048/jkm.22043

A traditional East Asian herbal complex, Majainhwan for constipation in Parkinson's disease: A retrospective study  

Jun Ho Cho (Department of Korean Medicine Cardiology and Neurology, Graduate School, Kyung Hee University)
Chul Jin (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Seungwon Kwon (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Seung-Yeon Cho (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Seong-Uk Park (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Woo-Sang Jung (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Sang-Kwan Moon (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Jung-Mi Park (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Chang-Nam Ko (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Ki-Ho Cho (Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University)
Publication Information
The Journal of Korean Medicine / v.43, no.4, 2022 , pp. 8-19 More about this Journal
Abstract
Objectives: Parkinson's disease (PD) patients experience various non-motor symptoms, among which constipation is the second most common after anosmia. However, there are no clear guidelines or effective treatment for constipation in PD. Methods: To investigate the efficacy of Majainhwan (MH) on constipation in patients with PD, we conducted a retrospective chart review study of PD or Parkinsonism patients with constipation who received outpatient or inpatient treatment and whose previous laxatives were replaced by MH from August 2016 to July 2019. Results: In this study, a total of 68 patients' medical records were reviewed. Among the 44 outpatients with MH treatment, "effective" results were observed in 86.4% patients. Similarly, among the 24 inpatients, "effective" results were noted in 95.8% patients. The adverse effect was "diarrhea" reported in five cases. Conclusion: Based on these findings, we could suggest that MH is relatively safe and may be effective in the treatment of constipation in patients with PD.
Keywords
Majainhwan; Mashiningan; Mazirenwan; Constipation; Parkinson's disease;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 M. Zhang, Y. Gan, X. Wang, et al., "Gait performance and non-motor symptoms burden during dual-task condition in Parkinson's disease," Neurol Sci, 2022. doi: 10.1007/s10072-022-06411-2. Epub ahead of print.   DOI
2 K. M. Prakash, N. V. Nadkarni, W.K. Lye et al., "The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study," Eur J Neurol, vol. 23, no. 5, pp. 854-860, 2016. doi: 10.1111/ene.12950.   DOI
3 H. Chen, E.J. Zhao, W. Zhang et al., "Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis," Transl Neurodegener, vol. 4, no. 1, pp. 1, 2015. doi: 10.1186/2047-9158-4-1.   DOI
4 K.L. Adams-Carr, J.P. Bestwick, S. Shribman et al., "Constipation preceding Parkinson's disease: a systematic review and meta-analysis," J Neurol Neurosurg Psych, vol. 87, no. 7, pp. 710-716, 2016. doi: 10.1136/jnnp-2015-311680.   DOI
5 L. Klingelhoefer, H. Reichmann., "Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors," Nat Rev Neurol, vol. 11, no. 11, pp. 625-636, 2015. doi: 10.1038/nrneurol.2015.197.   DOI
6 C. H. Hawkes, K. Del Tredici and H. Braak, "Parkinson's disease: a dual-hit hypothesis," Neuropathol Appl Neurobiol, vol. 33, no. 6, pp. 599-614, 2007. doi: 10.1111/j.1365-2990.2007.00874.x.   DOI
7 H.L. Chiang, C.H. Lin, "Altered gut microbiome and intestinal pathology in Parkinson's disease," J Mov Disord, vol. 12, no. 2, pp. 67-83, 2019. doi: 10.14802/jmd.18067.   DOI
8 I.D. Wilson, J. K. Nicholson, "Gut microbiome interactions with drug metabolism, efficacy, and toxicity," Transl Res, vol. 179, pp. 204-222, 2017. doi: 10.1016/j.trsl.2016.08.002.   DOI
9 J.W. Kim, "Constipation," Korea Ass Internal Med, vol. 04, pp. 344-348, 2017.
10 G.F. Longstreth, W. Grant Thompson, W.D. Chey et al., "Functional bowel disorders," Gastroenterology, vol. 130, no. 5, pp. 1480-1491, 2006. doi: 10.1053/j.gastro.2005.11.061.   DOI
11 J. Xu, L. Wang, X. Chen, W. Le., "New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson's Disease," Front Aging Neurosci, vol. 14, pp. 917499, 2022. doi: 10.3389/fnagi.2022.917499.   DOI
12 C. Pont-Sunyer, Y. Compta, T. Brucke et al., "The onset of nonmotor symptoms in Parkinson's disease (The ONSET PD Study)," Mov Dis, vol. 30, no. 2, pp. 229-237, 2015. doi: 10.1002/mds.26077.   DOI
13 S. Mori, T. Tomita, K. Fujimura et al., "A randomized double-blind placebo-controlled trial on the effect of magnesium oxide in patients with chronic constipation," J Neurogastroenterol Motil, vol. 25, no. 4, pp. 563-575, 2019. doi: 10.5056/jnm18194.   DOI
14 H. Omotani, M. Yasuda, R. Ishii et al., "Analysis of l-DOPA-derived melanin and a novel degradation product formed under alkaline conditions," J Pharm Biomed Anal, vol. 125, pp. 22-26, 2016. doi: 10.1016/j.jpba.2016.03.019.   DOI
15 R. Sakakibara, T. Odaka, Z. Lui et al., "Dietary herb extract dai-kenchu-to ameliorates constipation in parkinsonian patients," Mov Dis, vol. 20, no. 2, pp. 261-262, 2005. doi: 10.1002/mds.20352.   DOI
16 Y. Nakae, T. Kosuge, Y. Kumagai et al., "The effectiveness of Mashiningan for constipation in Parkinson's disease," Kampo Med, vol. 67, no. 2, pp. 131-136, 2016. doi: 10.3937/kampomed.67.131   DOI
17 J. Kwak, Y.H. Kim, J.H. Park et al., "A case report on Parkinson's disease Soyangin patient with abdominal pain and constipation," J Sasang Constitut Med, vol. 28, no. 3, pp. 276-285, 2016. doi: 10.7730/JSCM.2016.28.3.276   DOI
18 L.J. O'Donnell, J. Virjee, K.W. Heaton, "Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate," BMJ, vol. 300, no. 6722, pp. 439-440, 1990. doi: 10.1136/bmj.300.6722.439.   DOI
19 Y.G. Park, M.S. Lee, N.Y. Bae, "A case study of Soyangin patient with early-stage Parkinson's disease diagnosed as upper wasting-thirst pattern," J Sasang Constitut Med, vol. 27, no. 1, pp. 178-188, 2015. doi: 10.7730/JSCM.2015.27.1.178   DOI
20 I.S. Lee, J.H. Won, "A case report of Soyangin patient with early-stage Parkinson's disease treated with Hyeongbangjihwhang-tang," J Sasang Constitut Med, vol. 28, no. 2, pp. 184-192, 2016. doi: 10.7730/JSCM.2016.28.2.184   DOI
21 L.L. Zhong, C.W. Cheng, Y. Chan, et al., "Chinese herbal medicine (Ma Zi Ren Wan) for functional constipation: study protocol for a prospective, double-blinded, double-dummy, randomized controlled trial," Trials, vol. 14, pp. 366, 2013. doi: 10.1186/1745-6215-14-366.   DOI
22 L.M. de Lau, M.M. Breteler., "Epidemiology of Parkinson's disease," Lancet Neurol, vol. 5, no. 6, pp. 525-535, 2006. doi: 10.1016/S1474-4422(06)70471-9.   DOI
23 V.W. Yong, Y.J. Tan, Y.D. Ng, et al., "Progressive and accelerated weight and body fat loss in Parkinson's disease: A three-year prospective longitudinal study," Parkinsonism Relat Disord, vol. 77, pp. 28-35, 2020. doi: 10.1016/j.parkreldis.2020.06.015.   DOI
24 C.W. Cheng, Z.X. Bian, L.X. Zhu et al., "Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation," Am J Gastroenterol, vol. 106, no. 1, pp. 120-129, 2011. doi: 10.1038/ajg.2010.305.   DOI
25 Y. Harada, S. Iizuka, Y. Saegusa et al., "Mashiningan mproves opioid-induced constipation in rats by activating cystic fibrosis transmembrane conductance regulator chloride Channel," J Pharmacol Exp Ther, vol. 362, no. 1, pp. 78-84, 2017. doi: 10.1124/jpet.117.240630.   DOI
26 O. Bernal-Pacheco, N. Limotai, C. L. Go et al., "Nonmotor manifestations in Parkinson disease," Neurologist, vol. 18, no. 1, pp. 1-16, 2012. doi: 10.1097/NRL.0b013e31823d7abb.   DOI
27 C. A. Davie, "A review of Parkinson's disease," Br Med Bull, Vol. 86, pp. 109-127, 2008. doi: 10.1093/bmb/ldn013.   DOI